These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30238327)

  • 1. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.
    He W; Yan L; Wang M; Li Q; He M; Ma Z; Ye Z; Zhang Q; Zhang Y; Qiao N; Lu Y; Ye H; Lu B; Shou X; Zhao Y; Li Y; Li S; Zhang Z; Shen M; Wang Y
    Endocrine; 2019 Jan; 63(1):27-35. PubMed ID: 30238327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China.
    Li YL; Zhang S; Guo XP; Gao L; Lian W; Yao Y; Deng K; Wang RZ; Xing B
    Arch Endocrinol Metab; 2019; 63(2):157-166. PubMed ID: 30916168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
    Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels.
    Mori K; Iwasaki Y; Kawasaki-Ogita Y; Honjo S; Hamamoto Y; Tatsuoka H; Fujimoto K; Ikeda H; Wada Y; Takahashi Y; Takahashi J; Koshiyama H
    J Endocrinol Invest; 2013 Nov; 36(10):853-9. PubMed ID: 23665535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
    Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
    Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly.
    Stelmachowska-Banaś M; Zieliński G; Zdunowski P; Podgórski J; Zgliczyński W
    Neurol Neurochir Pol; 2011; 45(4):328-34. PubMed ID: 22101993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Fasting C-Peptide Acts as a Promising Predictor of Improved Glucose Tolerance in Patients With Acromegaly After Transsphenoidal Surgery: A Retrospective Study of 64 Cases From a Large Pituitary Center in China.
    Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Feng M; Bao X; Xing B
    Front Endocrinol (Lausanne); 2019; 10():736. PubMed ID: 31736874
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuation analysis of postoperative secretory status in patients operated for acromegaly.
    Graillon T; Castinetti F; Boucekine M; Cuny T; Morange I; Fuentes S; Figarella-Branger D; Albarel F; Brue T; Dufour H
    Ann Endocrinol (Paris); 2020 Feb; 81(1):11-17. PubMed ID: 31982107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.
    Kasayama S; Otsuki M; Takagi M; Saito H; Sumitani S; Kouhara H; Koga M; Saitoh Y; Ohnishi T; Arita N
    Clin Endocrinol (Oxf); 2000 May; 52(5):549-55. PubMed ID: 10792333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
    Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
    PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.